December 2020 FDA Recall Ketorolac Tromethamine by Fresenius Kabi Usa, Llc
D-0184-2021 - Presence of Particulate Matter - found in reserve sample vials at the firm.
This Class II drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on December 17, 2020 for the product Ketorolac Tromethamine. The FDA reported the reason for recall as presence of particulate matter - found in reserve sample vials at the firm.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0184-2021
Presence of Particulate Matter - found in reserve sample vials at the firm.
12-17-2020
01-06-2021
490,633 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Fresenius Kabi USA, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
USA Nationwide and Puerto Rico
06-20-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02
Batch or Lot Expiration Information
Batch# 6121125, Exp 02/2021